Principal, Venture Investments
- Part of JJDC since 2020
- Based in New York City
- Focus on Consumer Health investments
- Fun fact: conquered his fear of heights by skydiving
Based in New York City, Anurag has extensive experience analyzing and advising companies at various stages in their growth cycle across industries. Having joined JJDC in 2020, Anurag now works closely with JJDC portfolio companies to tackle challenges that companies face as they try to commercialize and scale their innovations, establish successful business models, and attain the right strategic exit.
Previously, Anurag was the Global Head of Strategic Transactions within the Consumer Health Business Development team at Johnson & Johnson, where he led acquisitions, equity investments and other strategic transactions. During his four years with the group, he was involved in a number of key transactions, including the acquisition of Dr Ci:Labo brand and Zarbee’s Naturals in 2018 and OGX brand in 2016. In 2019, Anurag additionally acted as the Interim Head of JLABS@NYC.
Prior to joining Johnson & Johnson, Anurag spent close to a decade in the Mergers & Acquisitions Group within the Investment Banking Division at Credit Suisse in New York, where he advised on over $60 billion of announced acquisitions, divestitures, joint ventures, corporate restructurings and takeover defense transactions across various industry verticals. Anurag started his career in Product Development at Oracle Corporation in their Advanced Supply Chain Planning Division in Redwood Shores, California, where he was responsible for designing and developing algorithms for supply chain scheduling.
Anurag holds a B.Tech. in Mechanical Engineering from the Indian Institute of Technology in New Delhi, an MS in Industrial Engineering & Operations Research from the University of Florida and an MBA from the University of Chicago Booth School of Business.